23.1 C
New York
Wednesday, June 17, 2026

Tag: Brazil

DLA Piper advises Grupo Cox in US$4.2 billion Iberdrola Mexico acquisition

NEW YORK, Aug. 2, 2025 /PRNewswire/ -- DLA Piper advised Grupo Cox (Cox), a leading Spanish multinational water and energy company, in its acquisition...

DLA Piper advises Grupo Cox in US$4.2 billion Iberdrola Mexico acquisition

NEW YORK, Aug. 1, 2025 /PRNewswire/ -- DLA Piper advised Grupo Cox (Cox), a leading Spanish multinational water and energy company, in its acquisition...

Software-defined Wide Area Network (SD-WAN) Market worth $21.67 billion by 2030 | MarketsandMarkets™

DELRAY BEACH, Fla., Aug 1, 2025 /PRNewswire/ --According to MarketsandMarkets™, the Software-defined Wide Area Network Market is expected to grow to USD 21.67 billion by 2030...

Software-defined Wide Area Network (SD-WAN) Market worth $21.67 billion by 2030 | MarketsandMarkets™

DELRAY BEACH, Fla., Aug 1, 2025 /PRNewswire/ --According to MarketsandMarkets™, the Software-defined Wide Area Network Market is expected to grow to USD 21.67 billion by 2030...

Suppositories Market Worth $2.05 billion by 2030 with 4.7% CAGR | MarketsandMarkets™

DELRAY BEACH, Fla., Aug. 1, 2025 /PRNewswire/ -- The global Suppositories Market, valued at US$1.56 billion in 2024 stood at US$1.63 billion in 2025 and...

Nexalin Technology Appoints Highly Experienced Financial Leader Justin Van Fleet as CFO to Support Nexalin’s Next Phase of Growth and Strategic Initiatives

HOUSTON, TX, Aug. 01, 2025 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) (the “Company” or “Nexalin”), the leader in Deep Intracranial Frequency Stimulation (DIFS™) of the brain, today announced the appointment of Justin Van Fleet, CPA, as Chief Financial Officer, effective August 1, 2025.

The Sixth CASI Sustainability Forum Concludes Successfully in Malaysia: Driving ASEAN Collaboration and Talent Development in Sustainable Finance

BEIJING and KUALA LUMPUR, Malaysia, Aug. 1, 2025 /PRNewswire/ -- The SIDC-CASI SRI Conference 2025, jointly organized by the Securities Industry Development Corporation (SIDC) and...

Ingredion Incorporated Delivers Solid Second Quarter Results and Improves Full-Year Outlook

WESTCHESTER, Ill., Aug. 01, 2025 (GLOBE NEWSWIRE) -- Ingredion Incorporated (NYSE: INGR), a leading global provider of ingredient solutions to the food and beverage manufacturing industry, today reported its 2025 second quarter results.

Statkraft to sell Enerfín’s activities in Canada to Atlantica Sustainable Infrastructure

(Montreal, Canada/Oslo, Norway) Statkraft has signed an agreement to sell Enerfín Canada, its renewables portfolio in Canada, to Atlantica Sustainable Infrastructure Ltd. The transaction includes the team, operating wind farms and a development portfolio.

BW Energy: Second quarter and first half 2025 results 

BW Energy delivered strong operational performance in the first half of 2025, driven by high production uptime, competitive cost levels, and a solid safety record with zero lost time incidents. The Company’s project portfolio continues to advance, with final investment decisions taken on both the Maromba development and the Golfinho Boost project. In addition, a substantial oil discovery was made at the Bourdon prospect in the Dussafu area, further expanding BW Energy’s resource base. Backed by strong cash generation and a resilient financial structure, BW Energy is well placed to drive growth and create long-term shareholder value. 

AES Reports Second Quarter 2025 Results; On Track to Deliver on 2025 Guidance and Long-Term Targets

Second Quarter 2025 Renewables SBU Adjusted EBITDA Grew 56% Versus Second Quarter 2024 Strategic Accomplishments On track to add 3.2 GW of new projects in operation in...

Knight Therapeutics Announces Regulatory Supplemental Submission of MINJUVI® (tafasitamab) for Follicular Lymphoma in Brazil

MONTREAL, July 31, 2025 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc., (TSX: GUD) ("Knight") a pan-American (ex-USA) specialty pharmaceutical company, announced today that its Brazilian affiliate, United Medical Ltda., has submitted a supplemental application to ANVISA, the Brazilian health regulatory agency, seeking approval for an additional indication for MINJUVI® (tafasitamab) in combination with rituximab and lenalidomide for the treatment of adult patients with previously treated follicular lymphoma (FL). The supplemental application for the additional indication was selected for review under Project Orbis.

FMC Corporation obtains registration in Great Britain for Fundatis® herbicide powered by Isoflex® active

PHILADELPHIA, July 31, 2025 /PRNewswire/ -- FMC Corporation (NYSE: FMC), a leading global agricultural sciences company, today announced it has received registration for Fundatis®...

Brookfield Infrastructure Reports Solid Second Quarter 2025 Results

BROOKFIELD, News, July 31, 2025 (GLOBE NEWSWIRE) -- Brookfield Infrastructure Partners L.P. (Brookfield Infrastructure, BIP, or the Partnership) (NYSE: BIP; TSX: BIP.UN) today announced its results for the second quarter ended June 30, 2025.

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsBrazil